Table 3 Logistic regression of the association between aortic stiffness and clinical factors with CVD events
Hazard ratio | 95% CI | P value | |
|---|---|---|---|
AAD | 0.49 | (0.25; 0.95) | 0.01 |
DAD | 0.70 | (0.41; 1.20) | 0.19 |
PWV | 1.07 | (0.90; 1.26) | 0.45 |
Age | 1.05 | (1.00; 1.10) | 0.07 |
Gender | 0.19 | (0.02; 1.52) | 0.12 |
Body mass index | 0.97 | (0.86; 1.09) | 0.62 |
Duration of diabetes | 0.99 | (0.88; 1.10) | 0.80 |
HbA1c | 0.98 | (0.95; 1.02) | 0.35 |
Median HbA1c since diagnosis | 1.01 | (0.97; 1.04) | 0.75 |
Maximum HbA1c since diagnosis | 1.00 | (0.97; 1.02) | 0.74 |
Microalbuminuria | 2.19 | (0.77; 6.16) | 0.13 |
24 h systolic BP | 1.02 | (0.99; 1.06) | 0.18 |
24 h diastolic BP | 1.01 | (0.95; 1.06) | 0.80 |
Total cholesterol | 0.89 | (0.56; 1.43) | 0.64 |
Smoking | 3.38 | (1.03; 11.15) | 0.05 |
Serum aldosterone | 1.00 | (0.99; 1.00) | 0.33 |
High sensitivity C reactive protein | 0.99 | (0.90; 1.09) | 0.87 |